DUBLIN, June 2, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Regenerative Medicine Market 2016-2020" report to their offering.
The report forecasts the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend that will positively impact the market is the high number of regenerative medicines in the pipeline. The global regenerative medicine market may witness the development and launch of many new therapies during the forecast period. There are many regenerative medicine pipeline products that are in different stages of development, ranging from discovery, pre-clinical phase to mid-stage and late-stage phase. As per the estimation in 2015, more than 2,500 regenerative medicine were under clinical trials.
A key growth driver for this market is the increased focus on cell therapy products. There are more than 40 approved cell therapy products in the market. Most small and large biotech companies are working on various cell types such as progenitor cells, adult and embryonic stem cells, and iPSCs. These cells have proved their efficacy in the treatment of chronic heart failure, cancer, and diabetes. Most of the cell therapy products are marketed for wound and dermal graft; however, there are only few products for cancer.
Further, the report states that one challenge that could hamper market growth is the high cost and failure rate in clinical trials.
- MiMedx Group
- Zimmer Biomet
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline portfolio
PART 06: Market landscape
PART 07: Market segmentation by product
PART 08: Market segmentation by application
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/dnp4zk/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-regenerative-medicine-market-2016-2020---increased-focus-on-cell-therapy-products---research-and-markets-300278772.html
SOURCE Research and Markets